Page 1 of Clinical Trials for long acting injectable, 318 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
A Study to Evaluate Social Functioning of Long Acting Injectable Risperidone and Oral Risperidone in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder
Last Updated: December 9, 2011
Condition(s): Schizophrenia; Psychotic Disorders
2
Terminated
Family Perspectives:Treatment of Psychiatric Illnesses With Atypical Long Acting Injectable Antipsychotic Medication
Last Updated: January 4, 2007
Condition(s): Psychotic Disorders
3
Completed
Medical Chart Review of Patients on Long-term Treatment With Long-acting Injectable Risperidone
Last Updated: April 26, 2010
Condition(s): Schizophrenia; Schizoaffective Disorder
4
Recruiting
High Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to Risperidone
Last Updated: November 1, 2010
Condition(s): Schizophrenia; Schizoaffective Disorder
5
Completed
A Pharmacokinetic and Safety Study of Risperidone Long Acting Injectable in Schizophrenic Patients
Last Updated: May 16, 2011
Condition(s): Schizophrenia
6
Completed
A Comparison of the Pharmacokinetics and Safety of Long-acting Injectable Risperidone When Administered to Gluteal or Deltoid Intramuscular Injection Sites in Stable Schizophrenia Patients.
Last Updated: June 2, 2011
Condition(s): Schizophrenia
7
Completed
Characterization of Intramuscular Injections of Risperidone 4 Week Long-acting Injectable (LAI) Formulation in the Buttock of Patients With Schizophrenia
Last Updated: May 17, 2011
Condition(s): Psychotic Disorders; Schizophrenia
8
Completed
Long-Acting Injectable Risperidone in the Treatment of Schizophrenia
Last Updated: May 3, 2011
Condition(s): Schizoaffective Disorder; Schizophrenia
9
Completed
A Trial of Long-Acting Injectable Risperidone in the Treatment of Methamphetamine Dependence
Last Updated: January 3, 2008
Condition(s): Methamphetamine Dependence
10
Completed
A Study to Evaluate the Efficacy and Safety of Risperidone for the Prevention of Mood Episodes in the Treatment of Patients With Bipolar I Disorder
Last Updated: May 19, 2011
Condition(s): Bipolar Disorder
11
Recruiting
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Last Updated: May 18, 2012
Condition(s): Schizophrenia; Bipolar Disorder
12
Completed
A Pilot Study of the Use of Risperidone Long Acting Injectable in the Treatment of Patients With Recent Onset Psychosis
Last Updated: March 3, 2011
Condition(s): Schizophrenia; Schizophreniform Disorders; Schizoaffective Disorder
13
Terminated
Long-Acting Injectable Naltrexone Treatment of Alcohol Dependence in Primary Care vs. in Specialized Chemical Dependence Treatment: A Pilot Trial
Last Updated: October 21, 2011
Condition(s): Alcohol Dependence; Veterans
14
Completed
Injection Site Tolerability of Multiple Dose Treatment With Long-acting Injectable Risperidone Administered Via Deltoid Muscle in Chronic Schizophrenia Patients.
Last Updated: May 17, 2011
Condition(s): Schizophrenia
15
Completed
A Study of the Efficacy, Safety, and Quality of Life of Patients With Schizophrenia Receiving Treatment With a Long-acting Injectable Formulation of Risperidone
Last Updated: June 17, 2011
Condition(s): Schizophrenia; Schizoaffective Disorder
16
Completed
A Study of the Efficacy and Safety of Long-acting Injectable Risperidone and Risperidone Tablets in Patients With Schizophrenia
Last Updated: May 16, 2011
Condition(s): Schizophrenia
17
Completed
A Long Term Study of Safety for Long Acting Injectable Risperidone in Patients With Schizophrenia or Schizoaffective Disorder.
Last Updated: May 16, 2011
Condition(s): Schizophrenia; Schizoaffective Disorder
18
Completed
RiSPECT: Risperdal Safety Protocol Evaluation Consta Treatment, a Post Authorization Safety Survey to Obtain Information on the Safety and Efficacy of Risperidone When Used in Routine Clinical Practice
Last Updated: October 15, 2010
Condition(s): Schizophrenia; Psychotic Disorders; Schizoaffective Disorder
19
Completed
Treatment With Risperidone Long Acting Injectable (RLAI) in an Early Phase of Psychosis
Last Updated: May 16, 2011
Condition(s): Schizophrenia; Psychotic Disorders; Schizoaffective Disorder
20
Completed
A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder
Last Updated: May 17, 2011
Condition(s): Schizophrenia; Psychotic Disorders

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=long+acting+injectable

Page 1 of Clinical Trials for long acting injectable, 318 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About